corticosteroids are used to establish the endocrine disorder dx of ___
cushings syndrome
mifepristone is a _____ receptor antagonists
glucocorticoid
prednisone is a ____ agonist, fludrocortisone is a a ___ agonist
glucocorticoids
mineralocorticoids
aldosterone and cortisol bind with ___ affinity to the ___ receptor
equal affinity to the MR receptor
what enzyme converts cortisol from active to inactive back to active form? and what is the inert steroid name?
active: cortisol (corticosterone, prednisolone)
- — [11 B-HSD2] —> inactive: cortisone, 11-dehydrocortisone, prednisone—-[11 B-HSD1]—> active form
therapeutic effects of corticosteroids
immunosupression (transplants, cancer, autoimmune dz)
anti-inflammatory
anti-allergy
pain relief (secondary)
side effects of glucocorticoids
infections osteoporosis hyperglycemia weight gain "cushingoid" appearance HPA insufficiency (adrenal atrophy) HTN neuropsychiatric DO cataracts/glaucoma myopathies skin thinning
factors of corticosteroids that influence therapeutic and adverse affects
what is the criteria for initiating therapy with corticosteroids
2. chronic therapy (must be evidence foe use)
T/F corticosteroids cannot be given chronically without the risk of adverse affects
true
tx of addisons dz (primary adrenal insufficiency) and CAH
both: hydrocortisone and fludrocortisone
effects of corticosteroids on the immune system
decrease: Prostaglandins , leukotrienes, immune cells, cytokines and receptors, neutrophil and MO migration, cell adhesion molecules
= 1. decreased inflammation and mainfestations
corticosteroids affect of carbohydrate metabolism
increase gluconeogenisis increase glucose output increase glycogen synthesis decrease glucose uptake =HYPERGLYCEMIA
what causes inhibition of 11 B HSD2 ? what is the effect/
inhibitors: glycyrrhizin (licorice)
-excessive activation of MR receptor mediated by cortisol [ increase NA and H2O retention, increase K+ loss—>increase BP]
= HTN
corticosteroids drug dosing rules
____ can tx cancer of the adrenal gland (adrenal cortical carcinoma)
mitotane
“mighty tank”
name short, intermediate and long acting corticosteroids and the duration of action
short: 8-12 hours
- hydrocortisone (cortisol)
- cortisone acetate
intermediate: 12-36 hrs
- prednisone / prednisolone / methylprednisolone
- triamcinolone
long: 36-72 hrs
- dexamethasone
- bethamethosone
*dexamethasone suppression test use to dx cause of Cushings syndrome
pharmokinetics and toxicities of prednisolone
(intermediate acting: 12-36hr ; glucocorticoid agonist)
pharmokinectics: duration of activity is longer than pharmokinectic T 1/2 of drug owing to gene transcription effects
- SE: adrenal suppression
___ is used in dx of adrenal insufficiency (addisons) and occasionally in tx of Cushings (hypercortisolism)
metyrapone
mifepristone MOA, clinical use and SE
two mineralocorticoid receptor antagonists, clinical use, pharmokinetics, and SE
ketoconazole MOA, use, SE
MOA: corticosteroids synthesis inhibitor
use: inhibits mammalian steroid hormone synthesis and FUNGAL ERGOSTEROL SYNTHESIS (tx fungal infections)
SE: many drug-drug CYP 450 interactions
what anti-thyroid medication takes weeks for the effects to start ? what is its MOA? and used for tx of? and SE?
radioactive idodine 131 sodium
-MOA: taken up by thyroid, collects in colloid, and creates permanent destruction and damage to thryoid
2 types of thioamides? MOA, SE, and tx use